VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, ...
Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...
Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, ...
Xenon Pharmaceuticals XENE reported a loss of $1.31 per share for the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.20. The company had incurred a loss of 84 cents ...
MONTGOMERY COUNTY, Md. (7News) — A long-awaited redevelopment project was approved for Montgomery County on Tuesday. VIVA White Oak is a potential $2.8 billion mixed-use development project that would ...
A hot potato: It shouldn't come as a surprise that fans of generative AI are pretty sensitive about the terminology and negativity surrounding it. OpenClaw creator Peter Steinberger, for example, says ...
Weather may have cancelled an annual Easter egg hunt in Kalamazoo, but that didn't stop the Easter Bunny for coming to town. Two arrested after search warrants yield guns, drugs in Berrien County Two ...
Zenon's Minion is the first boss you fight during the quest to slay Zenon in Code Vein 2. This battle occurs during the Slaying the Hero Zenon quest. This boss guide will provide info on how to beat ...
Connecticut-based Braidwell sold 1,779,953 Xenon Pharmaceuticals shares in the fourth quarter; the estimated transaction value was $74.76 million based on quarterly average prices. Meanwhile, the ...
Rapidata emerges to shorten AI model development cycles from months to days with near real-time RLHF
Despite growing chatter about a future when much human work is automated by AI, one of the ironies of this current tech boom is how stubbornly reliant on human beings it remains, specifically the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results